NVRO Nevro Corp

Price (delayed)

$144.19

Market cap

$5.01B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.55

Enterprise value

$5.26B

Sector: Healthcare
Industry: Medical Devices

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. ...

Highlights

The equity has soared by 70% YoY but it has contracted by 6% from the previous quarter
The EPS has increased by 6% year-on-year but it has declined by 3.2% since the previous quarter
The debt has soared by 82% year-on-year
NVRO's quick ratio is down by 49% year-on-year and by 6% since the previous quarter

Key stats

What are the main financial stats of NVRO
Market
Shares outstanding
34.78M
Market cap
$5.01B
Enterprise value
$5.26B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
13.63
Price to sales (P/S)
13.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.48
Earnings
Revenue
$363.19M
EBIT
-$61.31M
EBITDA
-$53.26M
Free cash flow
-$8.25M
Per share
EPS
-$2.55
Free cash flow per share
-$0.24
Book value per share
$10.58
Revenue per share
$10.49
TBVPS
$22.4
Balance sheet
Total assets
$775.67M
Total liabilities
$409.47M
Debt
$330.73M
Equity
$366.21M
Working capital
$492.36M
Liquidity
Debt to equity
0.9
Current ratio
3
Quick ratio
2.61
Net debt/EBITDA
-4.57
Margins
EBITDA margin
-14.7%
Gross margin
69.3%
Net margin
-24.2%
Operating margin
-17.2%
Efficiency
Return on assets
-11.3%
Return on equity
-23.3%
Return on invested capital
-8.4%
Return on capital employed
-11.6%
Return on sales
-16.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVRO stock price

How has the Nevro stock price performed over time
Intraday
-0.45%
1 week
-7%
1 month
-3.14%
1 year
22.55%
YTD
-16.7%
QTD
3.36%

Financial performance

How have Nevro's revenue and profit performed over time
Revenue
$363.19M
Gross profit
$251.65M
Operating income
-$62.3M
Net income
-$87.74M
Gross margin
69.3%
Net margin
-24.2%
NVRO's operating income is up by 19% YoY
The net margin is down by 13% year-on-year and by 6% since the previous quarter
The operating margin has grown by 12% YoY
The gross profit has contracted by 9% YoY

Growth

What is Nevro's growth rate over time

Valuation

What is Nevro stock price valuation
P/E
N/A
P/B
13.63
P/S
13.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.48
The EPS has increased by 6% year-on-year but it has declined by 3.2% since the previous quarter
The equity has soared by 70% YoY but it has contracted by 6% from the previous quarter
NVRO's P/B is 26% above its 5-year quarterly average of 10.8 and 4.8% above its last 4 quarters average of 13.0
The P/S is 51% higher than the 5-year quarterly average of 9.1 and 2.6% higher than the last 4 quarters average of 13.4
The revenue has contracted by 8% YoY

Efficiency

How efficient is Nevro business performance
NVRO's return on equity is up by 43% year-on-year and by 4.9% since the previous quarter
The company's return on invested capital rose by 42% YoY and by 10% QoQ
The ROA has grown by 39% YoY and by 5% from the previous quarter
The return on sales has increased by 7% year-on-year

Dividends

What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVRO.

Financial health

How did Nevro financials performed over time
NVRO's total assets is 89% greater than its total liabilities
NVRO's total assets has surged by 69% year-on-year
The total liabilities has soared by 67% YoY and by 2.1% from the previous quarter
The debt is 10% smaller than the equity
The debt has soared by 82% year-on-year
The equity has soared by 70% YoY but it has contracted by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.